National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011)
13Supply of botulinum toxin pharmaceutical benefits
Start here
Get a plain-English read of 13
Turn the raw legal text into a practical explanation grounded in National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011).
13 Supply of botulinum toxin pharmaceutical benefits
(1) A responsible person must supply a botulinum toxin pharmaceutical benefit to an eligible medical practitioner under this Special Arrangement if: (a) a request for supply of the botulinum toxin pharmaceutical benefit has been made by the eligible medical practitioner, or an authorised person, under section 14, for the treatment of an eligible patient; and (b) because of the request, the Chief Executive Medicare has placed an order for the botulinum toxin pharmaceutical benefit with the responsible person. (2) If botulinum toxin pharmaceutical benefit is supplied under subsection (1), the eligible medical practitioner, or a person authorised by the eligible medical practitioner to take delivery of botulinum toxin pharmaceutical benefits on behalf of the registered practice location at which the botulinum toxin pharmaceutical benefit was supplied, must sign any documents relating to the delivery of the botulinum toxin pharmaceutical benefit.